Is this you? Create Your Porfile
Avatar

P. Lagarde

Argonne National Laboratory

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where P. Lagarde is active.

Explore More

Publication

Featured researches published by P. Lagarde.

Cancer Radiotherapie | 2017

Doses aux organes à risque en radiothérapie conformationnelle et en radiothérapie stéréotaxique : les poumons

E. Blais; B. Pichon; A. Mampuya; M. Antoine; P. Lagarde; G. Kantor; C. Breton-Callu; C. Lefebvre; M. Gerard; A. Aamarcha; M. Ozsahin; J. Bourhis; P. Maingon; I. Troussier; N. Pourel

Radiation-induced lung disease (RILD) is common after radiation therapy and represents cornerstone toxicities after treatment of thoracic malignancies. From a review of literature, the objective of this article was to summarize clinical and non-clinical parameters associated with the risk of RILD in the settings of normo-fractionated radiotherapy and stereotactic body radiation therapy (SBRT). For the treatment of lung cancers with a normo-fractionated treatment, the mean lung dose (MLD) should be below 15-20Gy. For a thoracic SBRT, V20Gy<10% and MLD<6Gy are recommended. One should pay attention to central tumors and respect specific dose constraints to the bronchial tree. The recent technological improvements may represent an encouraging way to decrease lung toxicities. Finally, our team developed a calculator in order to predict the risk of radiation pneumonitis.

Cancer Radiotherapie | 2005

Proposition de sélection et délimitation des volumes cibles microscopiques péritumoraux dans les cancers de la cavité buccale et de l'oropharynx (aires ganglionnaires exclues)

M. Lapeyre; P. Henrot; M. Alfonsi; E. Bardet; R.J. Bensadoun; G. Dolivet; V. Favrel; O. Gallocher; P. Giraud; P. Graff; S. Guerif; P. Lagarde; E. Lartigau; V. Marchesi; P. Pommier; Michel Rives; J. Tortochaux; B. Toussaint; P. Verrelle; Jean-Henri Bourhis; G. Calais; Groupe oncologie radiothérapie tête et cou

Cancer Radiotherapie | 2005

Proposition de sélection et délimitation des volumes cibles microscopiques péritumoraux dans les cancers de la cavité buccale et de l'oropharynx (aires ganglionnaires exclues)Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)

M. Lapeyre; P. Henrot; M. Alfonsi; E. Bardet; René-Jean Bensadoun; G. Dolivet; V. Favrel; O. Gallocher; P. Giraud; P. Graff; S. Guerif; P. Lagarde; E. Lartigau; V. Marchesi; Pascal Pommier; Michel Rives; J. Tortochaux; B. Toussaint; Gilles Calais

Cancer Radiotherapie | 2004

Étude théorique d'une radiothérapie postopératoire avec modulation d'intensité d'un sarcome rétropéritonéal

E. Musat; G. Kantor; J. Caron; P. Lagarde; H. Laharie; E. Stoeckle; J. Angles; L. Gilbeau; Binh Bui

Cancer Radiotherapie | 2005

Radiothérapie adjuvante des sarcomes des tissus mous des membres : analyse du contrôle local en fonction des volumes irradiés et de la dose

Y. Milbéo; G. Kantor; H. Laharie; P. Lagarde; E. Stoeckle; F. Bonichon; L. Thomas; Véronique Brouste; Binh Bui

Cancer Radiotherapie | 2000

Traitement conservateur des sarcomes des tissus mous des membres.Évaluation du résultat fonctionnel selon l’échelle LENT-SOMAet le score de Enneking

N Tawfiq; P. Lagarde; Eberhard Stöckle; L. Thomas; Binh Bui; G. Kantor

Cancer Radiotherapie | 2008

Radiothérapie postopératoire des sarcomes des tissus mous des extrémités. Étude dosimétrique préliminaire comparative de la radiothérapie conformationnelle avec la tomothérapie hélicoïdale

L. Donnay; C. Dejean; E. Amsellem; H. Bourezgui; B.H. de Figueiredo; A. Duparc; J. Caron; H. Tournat; P. Lagarde; E. Stoeckle; G. Kantor

Cancer Radiotherapie | 2006

Approche conservatrice et fonctionnelle dans les sarcomes des tissus mous des membres : place de la radiothérapie

Y. Milbéo; G. Kantor; P. Lagarde; E. Stoeckle; A. Duparc; L. Thomas; Binh Bui

Cancer Radiotherapie | 2016

Practice evolution of hypofractionation in breast radiation therapy and medical impact

Dupin C; Vilotte F; P. Lagarde; A. Petit; C. Breton-Callu

Cancer Radiotherapie | 2015

Évolution des pratiques médicales d’hypofractionnement dans la radiothérapie pour cancer du sein et impact économique

Dupin C; F. Villote; P. Lagarde; A. Petit; C. Breton-Callu

Explore More

Collaboration

Dive into the P. Lagarde's collaboration.

Top Co-Authors
Avatar

G. Kantor

University of Bordeaux

View shared research outputs
Top Co-Authors
Avatar

Binh Bui

Argonne National Laboratory

View shared research outputs
Top Co-Authors
Avatar

E. Stoeckle

Argonne National Laboratory

View shared research outputs
Top Co-Authors
Avatar

C. Breton-Callu

Argonne National Laboratory

View shared research outputs
Top Co-Authors
Avatar

J. Caron

Argonne National Laboratory

View shared research outputs
Top Co-Authors
Avatar

A. Duparc

Argonne National Laboratory

View shared research outputs
Top Co-Authors
Avatar

A. Petit

Argonne National Laboratory

View shared research outputs
Top Co-Authors
Avatar

H. Laharie

Argonne National Laboratory

View shared research outputs
Top Co-Authors
Avatar

L. Thomas

Argonne National Laboratory

View shared research outputs
Top Co-Authors
Avatar

C. Dejean

Argonne National Laboratory

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge